Article | July 27, 2020

Effects Of Deep Cold Storage At -80°C On The Container Closure Integrity Of Sterile Product Vials

By Derek Duncan, Ph.D., Director at Lighthouse Instruments

Dry-Ice-Cryogenic-iStock-484428415

Certain sterile pharmaceutical products require deep cold storage, either at -80˚C or even cryogenic temperatures (down to -196˚C). Live viral vaccines, gene therapies, or products that contain active cells (cell therapies) often need deep cold storage to maintain stability and/or activity. Studies have shown that deep cold storage temperatures can introduce risk to the container closure integrity (CCI) of vial-rubber stopper combinations traditionally used to fill sterile pharmaceutical products. It is therefore critical that robust development work is done to understand the CCI performance of any primary packaging components used for a product needing deep cold storage and transport temperatures.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Pharmaceutical Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: